Results
|
|
1481.
|
|
|
|
1482.
|
The Cyclin D1 (CCND1) A870G polymorphism predicts clinical outcome to lapatinib and capecitabine in HER2-positive metastatic breast cancer. [electronic resource] by
- Labonte, M J
- Wilson, P M
- Yang, D
- Zhang, W
- Ladner, R D
- Ning, Y
- Gerger, A
- Bohanes, P O
- Benhaim, L
- El-Khoueiry, R
- El-Khoueiry, A
- Lenz, H-J
Producer: 20120920
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 23
Availability: No items available.
|
|
|
1483.
|
Endocrine therapy, new biologicals, and new study designs for presurgical studies in breast cancer. [electronic resource] by
- Dowsett, Mitch
- Smith, Ian
- Robertson, John
- Robison, Laura
- Pinhel, Isabel
- Johnson, Lindsay
- Salter, Janine
- Dunbier, Anita
- Anderson, Helen
- Ghazoui, Zara
- Skene, Tony
- Evans, Abigail
- A'Hern, Roger
- Iskender, Amanda
- Wilcox, Maggie
- Bliss, Judith
Producer: 20120319
In:
Journal of the National Cancer Institute. Monographs vol. 2011
Availability: No items available.
|
|
|
1484.
|
Activation of EGFR, HER2 and HER3 by neurotensin/neurotensin receptor 1 renders breast tumors aggressive yet highly responsive to lapatinib and metformin in mice. [electronic resource] by
- Dupouy, Sandra
- Doan, Van Kien
- Wu, Zherui
- Mourra, Najat
- Liu, Jin
- De Wever, Olivier
- Llorca, Frédérique Penault
- Cayre, Anne
- Kouchkar, Amal
- Gompel, Anne
- Forgez, Patricia
Producer: 20150625
In:
Oncotarget vol. 5
Availability: No items available.
|
|
|
1485.
|
|
|
|
1486.
|
The role of HGF/MET and FGF/FGFR in fibroblast-derived growth stimulation and lapatinib-resistance of esophageal squamous cell carcinoma. [electronic resource] by
- Saito, Shin
- Morishima, Kazue
- Ui, Takashi
- Hoshino, Hiroko
- Matsubara, Daisuke
- Ishikawa, Shumpei
- Aburatani, Hiroyuki
- Fukayama, Masashi
- Hosoya, Yoshinori
- Sata, Naohiro
- Lefor, Alan K
- Yasuda, Yoshikazu
- Niki, Toshiro
Producer: 20160108
In:
BMC cancer vol. 15
Availability: No items available.
|
|
|
1487.
|
[Development and biochemical characterization of EGFR/c-Met dual inhibitors]. [electronic resource] by
- Szokol, Bálint
- Gyulavári, Pál
- Baska, Ferenc
- Ibolya, Kurkó
- Greff, Zoltán
- Szántai, Kis-Csaba
- Zoltán, Orfi
- Peták, István
- Axel, Ullrich
- Vantus, Tibor
- Kéri, György
- Orfi, László
Producer: 20140404
In:
Acta pharmaceutica Hungarica vol. 83
Availability: No items available.
|
|
|
1488.
|
HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade. [electronic resource] by
- Prat, Aleix
- Pascual, Tomás
- De Angelis, Carmine
- Gutierrez, Carolina
- Llombart-Cussac, Antonio
- Wang, Tao
- Cortés, Javier
- Rexer, Brent
- Paré, Laia
- Forero, Andres
- Wolff, Antonio C
- Morales, Serafín
- Adamo, Barbara
- Brasó-Maristany, Fara
- Vidal, Maria
- Veeraraghavan, Jamunarani
- Krop, Ian
- Galván, Patricia
- Pavlick, Anne C
- Bermejo, Begoña
- Izquierdo, Miguel
- Rodrik-Outmezguine, Vanessa
- Reis-Filho, Jorge S
- Hilsenbeck, Susan G
- Oliveira, Mafalda
- Dieci, Maria Vittoria
- Griguolo, Gaia
- Fasani, Roberta
- Nuciforo, Paolo
- Parker, Joel S
- Conte, PierFranco
- Schiff, Rachel
- Guarneri, Valentina
- Osborne, C Kent
- Rimawi, Mothaffar F
Producer: 20200810
In:
Journal of the National Cancer Institute vol. 112
Availability: No items available.
|
|
|
1489.
|
A Genomic Analysis Workflow for Colorectal Cancer Precision Oncology. [electronic resource] by
- Corti, Giorgio
- Bartolini, Alice
- Crisafulli, Giovanni
- Novara, Luca
- Rospo, Giuseppe
- Montone, Monica
- Negrino, Carola
- Mussolin, Benedetta
- Buscarino, Michela
- Isella, Claudio
- Barault, Ludovic
- Siravegna, Giulia
- Siena, Salvatore
- Marsoni, Silvia
- Di Nicolantonio, Federica
- Medico, Enzo
- Bardelli, Alberto
Producer: 20200402
In:
Clinical colorectal cancer vol. 18
Availability: No items available.
|
|
|
1490.
|
Lapatinib resistance in HCT116 cells is mediated by elevated MCL-1 expression and decreased BAK activation and not by ERBB receptor kinase mutation. [electronic resource] by
- Martin, Aditi Pandya
- Miller, Anna
- Emad, Luni
- Rahmani, Mohammed
- Walker, Teneille
- Mitchell, Clint
- Hagan, Michael P
- Park, Margaret A
- Yacoub, Adly
- Fisher, Paul B
- Grant, Steven
- Dent, Paul
Producer: 20080918
In:
Molecular pharmacology vol. 74
Availability: No items available.
|
|
|
1491.
|
|
|
|
1492.
|
|
|
|
1493.
|
|
|
|
1494.
|
Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial. [electronic resource] by
- Robidoux, André
- Tang, Gong
- Rastogi, Priya
- Geyer, Charles E
- Azar, Catherine A
- Atkins, James N
- Fehrenbacher, Louis
- Bear, Harry D
- Baez-Diaz, Louis
- Sarwar, Shakir
- Margolese, Richard G
- Farrar, William B
- Brufsky, Adam M
- Shibata, Henry R
- Bandos, Hanna
- Paik, Soonmyung
- Costantino, Joseph P
- Swain, Sandra M
- Mamounas, Eleftherios P
- Wolmark, Norman
Producer: 20131227
In:
The Lancet. Oncology vol. 14
Availability: No items available.
|
|
|
1495.
|
|
|
|
1496.
|
Effect of lapatinib on the outgrowth of metastatic breast cancer cells to the brain. [electronic resource] by
- Gril, Brunilde
- Palmieri, Diane
- Bronder, Julie L
- Herring, Jeanne M
- Vega-Valle, Eleazar
- Feigenbaum, Lionel
- Liewehr, David J
- Steinberg, Seth M
- Merino, Maria J
- Rubin, Stephen D
- Steeg, Patricia S
Producer: 20080908
In:
Journal of the National Cancer Institute vol. 100
Availability: No items available.
|
|
|
1497.
|
|
|
|
1498.
|
Upregulation of mucin4 in ER-positive/HER2-overexpressing breast cancer xenografts with acquired resistance to endocrine and HER2-targeted therapies. [electronic resource] by
- Chen, Albert C
- Migliaccio, Ilenia
- Rimawi, Mothaffar
- Lopez-Tarruella, Sara
- Creighton, Chad J
- Massarweh, Suleiman
- Huang, Catherine
- Wang, Yen-Chao
- Batra, Surinder K
- Gutierrez, M Carolina
- Osborne, C Kent
- Schiff, Rachel
Producer: 20121123
In:
Breast cancer research and treatment vol. 134
Availability: No items available.
|
|
|
1499.
|
ErbBs inhibition by lapatinib blocks tumor growth in an orthotopic model of human testicular germ cell tumor. [electronic resource] by
- Juliachs, M
- Castillo-Ávila, W
- Vidal, A
- Piulats, J M
- Garcia Del Muro, X
- Condom, E
- Hernández-Losa, J
- Teixidó, C
- Pandiella, A
- Graupera, M
- Casanovas, O
- Germà, J R
- Villanueva, A
- Viñals, F
Producer: 20130611
In:
International journal of cancer vol. 133
Availability: No items available.
|
|
|
1500.
|
Anticancer activity of Celastrol in combination with ErbB2-targeted therapeutics for treatment of ErbB2-overexpressing breast cancers. [electronic resource] by
- Raja, Srikumar M
- Clubb, Robert J
- Ortega-Cava, Cesar
- Williams, Stetson H
- Bailey, Tameka A
- Duan, Lei
- Zhao, Xiangshan
- Reddi, Alagarasamy L
- Nyong, Abijah M
- Natarajan, Amarnath
- Band, Vimla
- Band, Hamid
Producer: 20110426
In:
Cancer biology & therapy vol. 11
Availability: No items available.
|